Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Smits

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
Ebiomedicine|March 22, 2024
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging studyIlanah J Pruis, Pieter Jan van Doormaal, Rutger K Balvers, et al.
International Journal of Cancer|May 4, 2024
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancerSophie H A E Derks, Edgar L van der Meer, Arjen Joosse, et al.
Journal of Cancer Policy|August 27, 2023
European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult gliomaAlessandro Bozzao, Damien Weber, Simon Crompton, et al.
IEEE Transactions on Medical Imaging|July 25, 2023
Evaluating the Predictive Value of Glioma Growth Models for Low-Grade Glioma After Tumor ResectionKarin A van Garderen, Sebastian R van der Voort, Maarten M J Wijnenga, et al.
Frontiers in Human Neuroscience|January 27, 2023
The effect of musicality on language recovery after awake glioma surgeryPablo R Kappen, Jan van den Brink, Johannes Jeekel, et al.
Neuro-Oncology|October 11, 2017
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, et al.
Neuro-Oncology|October 23, 2019
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteriaC Mircea S Tesileanu, Linda Dirven, Maarten M J Wijnenga, et al.
Neuro-Oncology Advances|March 7, 2025
Size matters: Early progression of melanoma brain metastases after treatment with immune checkpoint inhibitorsSophie H A E Derks, Li Shen Ho, Stephan R Koene, et al.
Neuro-Oncology Advances|February 22, 2021
Extent of radiological response does not reflect survival in primary central nervous system lymphomaMatthijs van der Meulen, Alida A Postma, Marion Smits, et al.
Neuro-Oncology|February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposalEmilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Ebiomedicine|March 22, 2024
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging studyIlanah J Pruis, Pieter Jan van Doormaal, Rutger K Balvers, et al.
International Journal of Cancer|May 4, 2024
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancerSophie H A E Derks, Edgar L van der Meer, Arjen Joosse, et al.
Journal of Cancer Policy|August 27, 2023
European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult gliomaAlessandro Bozzao, Damien Weber, Simon Crompton, et al.
IEEE Transactions on Medical Imaging|July 25, 2023
Evaluating the Predictive Value of Glioma Growth Models for Low-Grade Glioma After Tumor ResectionKarin A van Garderen, Sebastian R van der Voort, Maarten M J Wijnenga, et al.
Frontiers in Human Neuroscience|January 27, 2023
The effect of musicality on language recovery after awake glioma surgeryPablo R Kappen, Jan van den Brink, Johannes Jeekel, et al.
Neuro-Oncology|October 11, 2017
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, et al.
Neuro-Oncology|October 23, 2019
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteriaC Mircea S Tesileanu, Linda Dirven, Maarten M J Wijnenga, et al.
Neuro-Oncology Advances|March 7, 2025
Size matters: Early progression of melanoma brain metastases after treatment with immune checkpoint inhibitorsSophie H A E Derks, Li Shen Ho, Stephan R Koene, et al.
Neuro-Oncology Advances|February 22, 2021
Extent of radiological response does not reflect survival in primary central nervous system lymphomaMatthijs van der Meulen, Alida A Postma, Marion Smits, et al.
Neuro-Oncology|February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposalEmilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
Pageof 22